CRISPR/Cas13: A potential therapeutic option of COVID-19

Publication date: November 2020Source: Biomedicine & Pharmacotherapy, Volume 131Author(s): Melika Lotfi, Nima Rezaei
Source: Biomedicine and Pharmacotherapy - Category: Drugs & Pharmacology Source Type: research